RxDoctor Payments Data

Jeffrey Stevens, MD

Family Medicine · Maryville, TNNPI 1588600100

Payments from drug & device makers

$11,138in general payments, 2019–2025

Across 734 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • GSK$1K
  • Pfizer$1K
  • AstraZeneca$1K
  • AbbVie$975
  • Lilly USA, LLC$780
  • plus $4K from 47 others

What the payments were for

  • Food & beverage$11,132100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,138 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$137,394
Medicare patients
298
Services billed
4,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban186$174,592
JardianceEmpagliflozin61$63,791
JanuviaSitagliptin Phosphate47$60,446
MounjaroTirzepatide47$59,546
OzempicSemaglutide41$59,496
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$42,307
TrulicityDulaglutide23$29,521
FarxigaDapagliflozin Propanediol22$28,891
XareltoRivaroxaban25$26,384
Tresiba Flextouch U-200Insulin Degludec11$24,080
Synjardy XrEmpagliflozin/Metformin Hcl12$20,819
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$19,201
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$19,130
Spiriva RespimatTiotropium Bromide19$14,684
Lantus SolostarInsulin Glargine,hum.Rec.Anlog85$12,122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,083$174,592186 claims
Boehringer IngelheimJardiance, Synjardy Xr, Spiriva Respimat$622$99,29492 claims
Lilly USA, LLCMounjaro, Trulicity$780$89,06770 claims
MerckJanuvia, Belsomra$266$65,62759 claims
Novo NordiskOzempic$1,644$59,49641 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,068$51,76548 claims
GSKTrelegy Ellipta, Arnuity Ellipta$1,213$45,09859 claims
Johnson & JohnsonXarelto$42$26,38425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Maryville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →